BlackRock Fund Advisors’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$17.1M Buy
1,567,925
+183,375
+13% +$2M ﹤0.01% 2269
2016
Q3
$19.4M Buy
1,384,550
+85,022
+7% +$1.19M ﹤0.01% 2084
2016
Q2
$9.12M Buy
1,299,528
+58,309
+5% +$409K ﹤0.01% 2453
2016
Q1
$7.99M Buy
1,241,219
+13,593
+1% +$87.5K ﹤0.01% 2482
2015
Q4
$39.8M Sell
1,227,626
-77,231
-6% -$2.5M 0.01% 1634
2015
Q3
$34.8M Buy
1,304,857
+52,960
+4% +$1.41M 0.01% 1655
2015
Q2
$60.3M Buy
1,251,897
+141,321
+13% +$6.8M 0.01% 1406
2015
Q1
$67.6M Buy
1,110,576
+21,188
+2% +$1.29M 0.02% 1298
2014
Q4
$56.4M Buy
1,089,388
+191,574
+21% +$9.92M 0.01% 1382
2014
Q3
$39.5M Sell
897,814
-5,981
-0.7% -$263K 0.01% 1511
2014
Q2
$23.6M Buy
903,795
+228,782
+34% +$5.98M 0.01% 1918
2014
Q1
$17.6M Buy
675,013
+124,401
+23% +$3.25M 0.01% 2070
2013
Q4
$9.34M Buy
550,612
+279,651
+103% +$4.75M ﹤0.01% 2438
2013
Q3
$5.82M Buy
+270,961
New +$5.82M ﹤0.01% 2704